The search for new Alzheimer’s treatments just faced another setback — and now everything hinges on an approach that’s already run into trouble
|04/10/2018||Posted by BusinessMediaguide.Com under General World News||
- It’s been a while since we’ve had good news in the search for new Alzheimer’s drugs.
- On Wednesday, VTV Therapeutics, a small North Carolina biotech, said its Alzheimer’s drug failed a late-stage trial.
- Now, all eyes are on a set of treatments that go after the “amyloid hypothesis,” an approach that has already faced some setbacks.
It’s been a pretty bleak year in the search to find new Alzheimer’s treatments.